QuiaPEG Pharmaceuticals Holding AB (QUIA) — Capital Reinvestment Ratio
QuiaPEG Pharmaceuticals Holding AB (QUIA) has a Capital Reinvestment Ratio of 0.38x as of December 2015, meaning it reinvests 0% of its operating cash flow (Skr487.00K) in capital expenditures (Skr184.00K). Check QUIA intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
QuiaPEG Pharmaceuticals Holding AB Capital Reinvestment Ratio (2008–2015)
This chart tracks QuiaPEG Pharmaceuticals Holding AB's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see how efficiently does QuiaPEG Pharmaceuticals Holding AB generate cash.
Annual Capital Reinvestment Ratio for QuiaPEG Pharmaceuticals Holding AB (2008–2015)
Year-by-year Capital Reinvestment Ratio for QuiaPEG Pharmaceuticals Holding AB from 2008 to 2015. See QUIA FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 0.38x | Skr487.00K | Skr184.00K | ▲ +5518.2% |
| 2014 | 0.01x | Skr1.49 Million | Skr10.00K | ▼ -97.0% |
| 2011 | 0.22x | Skr2.55 Million | Skr573.00K | ▼ -12.2% |
| 2010 | 0.26x | Skr2.65 Million | Skr677.00K | ▲ +91.3% |
| 2009 | 0.13x | Skr1.82 Million | Skr244.00K | ▼ -96.2% |
| 2008 | 3.53x | Skr956.00K | Skr3.38 Million | — |